Lamisil and Diovan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lamisil (terbinafine hydrochloride) and Diovan (valsartan). Common drug interactions include pruritus among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Lamisil and Diovan. It is created by eHealthMe based on reports of 157 people who take the same drugs from the FDA, and is updated regularly.
What is Lamisil?
Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.
What is Diovan?
Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,154 Diovan users. Check the latest studies of Diovan.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
157 people who take Lamisil and Diovan together, and have interactions are studied.
What are the common drug interactions of Lamisil and Diovan, by gender? *
What are the common drug interactions of Lamisil and Diovan, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lamisil and Diovan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lamisil and Diovan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lamisil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Diovan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lamisil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Diovan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on terbinafine hydrochloride and valsartan (the active ingredients of Lamisil and Diovan, respectively), and Lamisil and Diovan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Megace cause Peritonitis? - now
- Could Valsartan cause Coronary Artery Stenosis? - a second ago
- Could Entyvio cause Serum Ferritin Decreased? - a second ago
- Could Methotrexate cause Pneumonia Lipoid? - a second ago
- Could Methotrexate cause Leishmaniasis? - 3 seconds ago
- Could Toprol-Xl cause Hypothyroidism? - 3 seconds ago
- Could Acth cause Drowsiness? - 3 seconds ago
- Could Actemra cause Hypoglycemia? - 5 seconds ago
- Lung Disorder and Pain Exacerbated - 5 seconds ago
- Could Methotrexate cause Large Intestinal Haemorrhage? - 6 seconds ago